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Lipoxygenases (LOXs) catalyze the regio- and stereospecific
dioxygenation of polyunsaturated membrane-embedded fatty
acids.We report here the 3.2Å resolution structure of 8R-LOX from
the Caribbean sea whip coral Plexaura homomalla, a LOX isozyme
with calcium dependence and the uncommon R chiral stereospeci-
ficity. Structural and spectroscopic analyses demonstrated calcium
binding in a C2-like membrane-binding domain, illuminating the
function of similar amino acids in calcium-activated mammalian
5-LOX, the key enzyme in the pathway to the pro-inflammatory
leukotrienes. Mutation of Ca2-ligating amino acids in 8R-LOX
resulted not only in a diminished capacity to bind membranes, as
monitored by fluorescence resonance energy transfer, but also in an
associated loss of Ca2-regulated enzyme activity. Moreover, a
structural basis for R chiral specificity is also revealed; creation of a
small oxygen pocket next to Gly428 (Ala in all S-LOX isozymes) pro-
moted C-8 oxygenation with R chirality on the activated fatty acid
substrate.
Lipoxygenases (LOXs)2 are non-heme iron dioxygenases that cata-
lyze the regio- and stereospecific formation of fatty acid hydroperoxides
from polyunsaturated fatty acids (1, 2). The substrates for the plant
enzymes are generally linoleic and linolenic acids, whereas the animal
enzymes catalyze the peroxidation of arachidonic acid in the biosynthe-
sis of leukotrienes and hydroxy fatty acids. Both plant and animal LOXs
are composed of two domains: a smaller N-terminal -barrel domain
and a larger -helical catalytic domain. The fold of the -barrel domain
resembles that of a “C2”module, calcium-dependentmembrane-target-
ing domains found inmany protein kinases and phospholipases (3), and
is equivalent in topology to the C2-like membrane-binding domain of
gangrene-toxin (4). Similarly, the-barrel domains of LOXs have also
been shown to mediate membrane binding (5–7).
The larger -helical catalytic domain (540 amino acids in rabbit
15S-LOX1) contains the non-heme iron essential for activity positioned
midway in a deep cavity that accommodates the hydrocarbon portion of
the substrate (8). Inmammalian 15S-LOX1, an exposedArg is proposed
to tether the carboxylate of the fatty acid substrate at the surface. Regio-
and stereospecificities of the various isozymes are thought to be gov-
erned by the shape and depth of the pocket, which must both position
the substrate for attack and allow the approach of O2, as well as the
orientation (head versus tail first) of the substrate in the cavity (9, 10).
Although the overall fold and geometry of the non-heme iron-binding
site are conserved with respect to the plant and animal enzymes, there
are significant differences in size, sequence, and specificity determi-
nants between these LOX classes (11).
The structures of rabbit 15S-LOX1 and the plant LOXs L1 and L3
have been described (8, 13–15), but no structure of a LOX that catalyzes
dioxygenation with R stereochemistry has been reported. Recently,
Coffa and Brash (16) observed that product stereochemistry is strongly
influenced by a single amino acid: anAla in the binding site of S-LOXs is
a Gly in the corresponding position of R-LOXs. Single-site mutant
LOXs in which Ala is exchanged with Gly and vice versa yield products
opposite in stereochemistry to those of the parent wild-type proteins.
Oxylipin biosynthesis studies have led to the identification of an
8R-LOX as part of a fusion protein with an allene-oxide synthase in the
soft coral Plexaura homomalla (17). The C-terminal LOX domain
shares significant sequence identity (41%) with the Ca2-regulated
mammalian 5-LOX, an asthma drug target due to its pivotal role in the
biosynthesis of the potent bronchoconstrictor leukotrienes. In contrast
tomammalian 5-LOX (18), 8R-LOX is remarkably stable and thus ame-
nable to crystallographic studies. An important aim of our structural
analysis of 8R-LOX is to explore the mechanistic basis of stereo control
in LOXs. We report here the 3.2-Å resolution structure of Ca2-acti-
vated 8R-LOX and demonstrate its calcium-dependent membrane tar-
geting with fluorescence resonance energy transfer (FRET).
MATERIALS AND METHODS
Site-directed Mutagenesis—Construction of mutants was performed
using the QuikChange site-directed mutagenesis kit (Stratagene). The
desired mutations were confirmed by sequencing.
Expression and Purification—Recombinant 8R-LOX and associated
mutants were expressed with anN-terminal His6 tag in BL21(DE3) cells
(Novagen). Following isopropyl -D-thiogalactopyranoside induction
at A600 nm  0.7, cells were grown in 2 Yeast Tryptone medium for
24 h at 20 °C. Cells were harvested (5000  g, 20 min, 4 °C), frozen at
80 °C, and subsequently lysed with BugBuster protein extraction rea-
gent (Novagen) with DNase I added. Cell debris was removed by cen-
trifugation at 46,000  g for 20 min at 4 °C, and the supernatant was
applied to nickel-nitrilotriacetic acid-agarose (Qiagen Inc.) equilibrated
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with 20 mM imidazole and 500 mM NaCl. After elution with 200 mM
imidazole, the proteinwas further purified by ion-exchange chromatog-
raphy using DE52 (Whatman) and Mono Q (Amersham Biosciences)
resins to yield the purified product. Calcium was removed by dialysis of
the concentrated protein samples in the presence of neutralized Chelex
100 (Bio-Rad) prior to dropwise flash-freezing in liquid N2 and storage
at 80 °C.
Crystallization—Plate-like crystals were grown in hanging-drop
vapor diffusion plates in 6.25%polyethylene glycol 8000 (Fluka), 100mM
imidazole acetate (pH 8.0), 100mMCaCl2, and 5% sucrose at 22 °C. The
crystals belong to space group P21 (a  69.6, b  78.0, and c  176.5 Å
and   96.7°) and diffract to 3.2 Å. There are two molecules/asym-
metric unit.
Data Collection and Phasing—Data were collected at 100 K on a
Nonius FR591 rotating anode fitted with a Mar345 detector. Crystals
were flash-frozen after transfer to mother liquor solutions in which the
concentration of ethylene glycol was incrementally increased to 40%.
Data processing and scaling were performed with Denzo and Scalepack
(19). The structure of 8R-LOX was solved by molecular replacement
withMOLREP (CCP4) (20)with a polyserinemodel of rabbit 15S-LOX1
(with which it shares 30% sequence identity) as the search model. Two
molecules were positioned to give a correlation coefficient of 36.9 and
an R-factor of 53.1. The first map was calculated with a polyalanine
model based on the molecular replacement results and 2Fo  Fc ampli-
tudes and revealed clear electron density for the non-heme iron and
chelating side chains. After multiple cycles of map interpretation with
program O (21) and refinement with strict non-crystallographic sym-
metry restraints inCNS (22), the finalmodel hasRwork andRfree values of
25.5 and 29.9, respectively.
Liposome Preparation—Large unilamellar vesicles were prepared
from a mixture of 75 mol of phosphatidylcholine and 25 mol of phos-
phatidylserine with 11 passes in amini-extruder assembly (Avanti Polar
Lipids). Liposomes used in FRET studies also containedN-(5-dimethyl-
aminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine (dansyl-DHPE; triethylammonium salt; Molec-
ular Probes) at 5% (w/w).
FRET Studies of Ca2-regulated Tryptophan Membrane Insertion—
The affinity of 8R-LOX for large unilamellar vesicles was determined by
monitoring the decrease in Trp fluorescence upon the addition of Ca2
to solutions of large unilamellar vesicles in which dansyl-DHPE was
incorporated at 5% (w/w). The concentration of the enzymewas 0.4M,
and the liposome concentration varied from10 to 80M in a sample size
of 3.4 ml. Fresh protein/dansyl-DHPE liposome solutions were pre-
pared for each data point; emission spectra were scanned (excitation
wavelength of 295 nm and emission wavelength of 320–400 nm) after
the addition of 2 mM EDTA; and the spectra were rescanned after the
addition of 4 mMCaCl2. A plot of the fractional loss of Trp fluorescence
signal (Fcalcium/Fcalcium) versus liposome concentration yielded a
hyperbolic binding curve when fitted by nonlinear regression analysis
with SigmaPlot.
Membrane insertion of wild-type and mutant 8R-LOXs was moni-
tored by a loss in Trp fluorescence (excitation wavelength of 295 nm)
and a gain in dansyl fluorescence upon the addition of Ca2 to solutions
of 8R-LOX and large unilamellar vesicles in which dansyl-DHPE was
incorporated at 5% (w/w). LOX and phospholipid concentrations were
1.2 and 260 M, respectively (in 50 mM Tris-HCl (pH 7.5) and 500 mM
NaCl), in a sample size of 185 l. Initial fluorescence spectra were taken
in the presence of 4mMEDTA;CaCl2was added to a final concentration
of 6mMprior to the second trace. All emission spectrawere recorded on
a Jasco FP-6300 spectrofluorometer with the bandwidth and band pass
both set to 5 nm. The data in Fig. 5 are reported as the normalized
difference in fluorescence at 517 nm in the absence and presence of
CaCl2 relative to that for the wild-type enzyme. Experiments were per-
formed in triplicate and are reported as the mean  S.D. of three inde-
pendent observations.
Stopped-flow Data Acquisition and Analysis—The effect of Ca2 on
8R-LOX catalysis was examined in an Applied Photophysics Model
SX17MV stopped-flow spectrometer operating in the absorbancemode
at 25 °C. Product (8R-hydroperoxyeicosatetraenoic acid) formation was
monitored at 235 nm with a cell path length of 0.2 cm. The enzyme
concentration was 10 nM in 50 mM Tris-HCl (pH 7.5), 500 mM NaCl,
and 2 mM EDTA. Assays were performed with 25 M arachidonic acid
(Cayman Chemical) in the absence and presence of large unilamellar
vesicles (260 M phospholipid) and in the presence of 4 mM CaCl2 and
large unilamellar vesicles. The reported concentrations of reagents are
those in the observation cell. Each kinetic trace was the average of at
least three individual measurements.
RESULTS
The Structure of 8R-LOX—The structure of 8R-LOX in the presence
of calcium was solved to 3.2 Å and refined to Rwork and Rfree values of
25.5 and 29.9, respectively (TABLE ONE). The overall fold is similar to
that of rabbit 15S-LOX1 (rootmean square deviation (r.m.s.d.) of 1.54Å
for 576 of 662 C- atoms), yet significant differences are found in the
loops on one side of the-barrel, in accessibility to the active site, and in
the substrate-binding pocket of the catalytic domain. 8R-LOX encom-
passes amino acids 374–1066 of the natural fusion protein with allene-
oxide synthase; but to simplify the discussion with respect to LOXs in
general, we have renumbered 8R-LOX to amino acids 2–694.
TABLE ONE




a, b, c (Å) 69.6, 78.0, 176.5
, ,  90.0°, 96.7°, 90.0°
Resolution (Å) 29.9 to 3.2
Rmerge a,b 10.1 (38.4)
I/I 9.7 (2.3)
Completeness (%) 98.5 (82.3)
Redundancy 3.3 (2.8)
Refinement










Bond length (Å) 0.008
Bond angle 1.51°
a Values in parentheses are for the highest resolution shell.
b Rmerge  Ii  	I
/Ii, where Ii is the intensity of the ith observation and 	I
 is the
mean intensity of the reflection.
c R  Fo  Fc/Fo, where Fo and Fc are the observed and calculated structure
factor amplitudes, respectively. Rfree was calculated using 5% of the total
reflections.
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8R-LOX is shaped roughly like a cylinder 100 Å in length and 60 Å
in diameter. The molecule is composed of two domains: an N-terminal
C2-like eight-stranded antiparallel -barrel domain (residues 2–114)
that constitutes the first third of the cylinder and a larger catalytic
domain (residues 115–694) that contains 23 helices and a three-
stranded antiparallel -sheet (Fig. 1). The catalytic iron is centrally
located in the -helical domain, but slightly displaced toward one sur-
face. The iron is chelated by His385, His390, His571, Asn575, and Ile694 via
its C terminus. A large elongated pocket passes by the iron, but this
pocket does not have clear access to the surface. The shortest route to
gain access to the cavity is by the movement of Tyr179 on a helix that
forms the outermost wall of the internal cavity.
FIGURE 1. The structure of 8R-LOX. a, the overall
fold of 8R-LOX. Shown are the N-terminal -barrel
(blue) and the -helical catalytic domain (red) with
associated Ca2 (yellow) and Fe3 (magenta) ions
and chelating residues. b, the 8R-LOX active site.
Ligands His385, His390, His571, Asn575, and Ile694
(yellow carbons) to the ferric iron are shown in a 2Fo 
Fc electron density map contoured at 1.75. The
substrate pocket-constricting Leu386 and Leu628
(magenta carbons) and R stereochemistry deter-
mining Gly428 (green carbons) are also shown.
FIGURE 2. Conservation of Ca2-binding residues in 8R-LOX, 5-LOX, and gangrene -toxin. a, a line of calcium-binding sites is located at one edge of the -domain of 8R-LOX.
The loops emanating from this edge have the exposed hydrophobic amino acids Trp41, Phe42, and Trp77. b, superposition of the C2-like domains of 8R-LOX (blue), 15S-LOX1 (gray),
and gangrene -toxin (red). 8R-LOX and gangrene -toxin Ca2 ions are shown in yellow and green, respectively. c, sequence conservation in 8R-LOX, 5-LOX, and gangrene -toxin.
8R-LOX, 15S-LOX1, and gangrene -toxin are aligned according to a structural superimposition, whereas 5-LOX is aligned according to sequence alone. Residues conserved in the
three LOXs are boxed, whereas residues conserved in 8R-LOX, 5-LOX, and gangrene -toxin are shown in yellow. Amino acids in 8R-LOX that participate in Ca2 binding (side chain
(red arrowheads) and main chain (black arrowheads) or membrane insertion (green arrowheads) are indicated.
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The C2-like -Barrel Domain Contains Calcium Sites and Exposed
Tryptophans—Structural features in the N-terminal -barrel domain
unique to the 8R-LOX structure were apparent in the initial electron
density map. The presence of 5 electron density peaks, an absolute
requirement for calcium in the crystallization, and the presence and
configuration of calcium-chelating amino acids led to the identification
of three calcium-binding sites. Ca2 is a crucial regulator of human
leukocyte 5-LOX activation (6) and its nuclear membrane localization
(23); but no crystal structure is available for this key enzyme, and these
calcium and membrane binding features are lacking in the previously
solved 15S-LOX1 structure.
If the N-terminal domain is viewed as two layers of -sheet, three
interwoven calcium-binding sites formed by five side chains (site 1:
Asp39 and Asp45; and site 2: Asp19, Asn44, and Glu47) and eight carbonyl
groups (Fig. 2) are located at one edge of the structure. The three calci-
um-binding sites, which form a ridge between the two layers of sheet,
seem to brace the structure by stabilizing loops that emanate from
strands 3 and 5. These loops, which traverse the ridge from one layer
to the other, contain surface-exposed hydrophobic amino acids (3:
Trp41 and Phe42; and5: Trp77). The loop that contains Trp77 is not well
defined in the electron density map, whereas the loop that contains
Trp41 is found nestled in a hydrophobic pocket of a symmetry mate in
the context of the crystal packing. These tryptophans lie at either end of
the line of the three Ca2 ions, with one near the “top” layer of the
-structure and the other at the “bottom” layer. As is evident from the
sequence alignment provided in Fig. 2, aswell as the superposition of the
-barrel domains of 8R-LOX and 15S-LOX1 (r.m.s.d. of 1.506 Å for 97
of 109 C- atoms) (8) and gangrene-toxin (r.m.s.d. of 1.460 Å for 93 of
113 C- atoms) (24), the calcium-binding residues found in 8R-LOX
correspond to those observed in the gangrene -toxin domain and pro-
posed for human 5-LOX (5), indicating the direct relevance of the
8R-LOX structure to elucidating aspects of calcium activation. Notably,
the calcium-binding ridge and putative membrane insertion loops are
on the same side of the molecule as the likely entrance to the cavity that
holds the catalytic iron. Thus, a two-pronged grip of the -barrel on the
membrane could serve to orient the catalytic domain to facilitate the
acquisition of substrate from the membrane phase.
Membrane Binding Affinity—The striking similarity of the structures
of the -barrel domains of 8R-LOX and gangrene -toxin (24) in the
presence of Ca2 led us to investigate the Ca2-dependent membrane
binding of 8R-LOX. We employed a FRET assay in which tryptophan
served as the donor and dansyl-phospholipids incorporated into lipo-
somes served as the acceptor. Membrane binding was indicated by a
reduction in Trp fluorescence (330 nm) accompanied by an increase in
dansyl fluorescence (517 nm). A binding isotherm based on the FRET
datawas constructed to determine the affinity of 8R-LOX for liposomes.
The plot of the fraction of Trp fluorescence quenched in the presence of
CaCl2 as a function of dansyl-liposome concentration is shown in Fig. 3.
The data could be fitted by nonlinear regression analysis to yield a
hyperbolic binding curve with a value of 11.4 2.7M for the 8R-LOX/
liposome dissociation constant. In control experiments in the absence
of Ca2, no quenching of Trp fluorescence by dansyl-liposomes was
observed, an indication that, in the absence of Ca2, 8R-LOX does not
bind membranes to an appreciable extent.
To evaluate the effects of the mutation of putative Ca2-ligating
amino acids on Ca2-mediated membrane insertion, the increase in
fluorescence at 517 nm upon the addition of CaCl2 to enzyme/dansyl-
liposome mixtures was monitored (excitation wavelength of 295 nm)
for wild-type and mutant 8R-LOXs at liposome concentrations of 260
M. As shown in Fig. 4, a distinct increase in fluorescence at 517 nmwas
observed for the wild-type enzyme with the addition of calcium to the
assay. Mutants in which a single Ca2-binding residue had been
replaced with Ala (D39A and E47A) exhibited diminished FRET prop-
erties, consistentwith a role for calcium inmembrane binding. A double
mutant (D39A/E47A) with calcium-binding residues from two of the
three sites mutated exhibited no FRET signal at all.
As mentioned above, the calcium-binding residues appear to anchor
the-barrel loops that containTrp41 andTrp77 (Fig. 2). These two loops
emanate from the same edge of the-sheet stack, one on each of the top
and bottom layers. Thus, the loops could simultaneously insert tomedi-
ate a two-pronged attachment to the membrane. In the context of the
crystal packing, the loop that contains Trp41 is found nestled in a hydro-
phobic cavity in a neighboring symmetry mate, whereas the loop that
contains Trp77 is not fully ordered.W41A exhibited2%of the increase
FIGURE 3. Quenching of 8R-LOX Trp fluores-
cence by dansyl-phosphatidylcholine/phos-
phatidylserine liposomes with the addition of
Ca2. The plot of Fcalcium/Fcalcium versus dan-
syl-liposome concentration could be fitted by
nonlinear regression analysis to yield a hyperbolic
binding curve with a Kd of 11.4  2.7 M. The pro-
tein concentration was 0.4 M in 50 mM Tris (pH
7.5), 500 mM NaCl, 2 mM EDTA. Emission spectra
were recorded (excitation wavelength of 295 nm),
and calcium was added to a concentration of 4 mM
prior to rescanning. F330 is the fluorescence at
330 nm.
Calcium Regulation of 8R-Lipoxygenase
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in fluorescence at 517 nm upon the addition of CaCl2. Similarly, W77A
exhibited only 4% of the wild-type signal. The loss of signal is consistent
with either the loss of membrane binding affinity and/or simply the loss
of a source of donor fluorescence for the FRET signal. The fact that both
mutations (W41A and W77A) individually led to a loss of signal sug-
gests that both loops are important for membrane binding or the FRET
signal.
Effect of Calcium on Enzyme Activity in the Presence of Liposomes—
Given the effect of calcium on membrane binding and the fact that the
substrate arachidonic acid partitions into the membrane phase, we
asked whether impaired membrane binding might result in a reduction
in enzyme activity in the presence of membranes. In a liposome-based
assay, wild-type activity was clearly stimulated upon the addition of
Ca2. However, a plot of the change in absorbance at 235 nm versus
time appears to suggest that the reaction reached completion at a con-
centration of 1 M substrate (Fig. 5a), whereas the concentration of
arachidonic acid in the reaction mixture was 25 M. However, not all
substrate is available to the membrane-bound enzyme, as the solubility
of arachidonic acid under similar conditions is appreciable (with a crit-
ical micellar concentration of 50 M (25)), and substrate in the aque-
ous phase is unavailable to the membrane-bound enzyme. Although
arachidonic acid on the outer leaflet is accessible and rapidly consumed,
subsequent turnovers depend on the re-equilibration of substrate
between the aqueous and membrane phases.
Wemonitored the activity of 8R-LOXmutants in which the calcium-
binding residues and putative membrane insertion residues were
mutated. The results of these experiments support the FRET data, as
mutations that abrogated binding of 8R-LOX to membranes also elim-
inated Ca2 stimulation of enzyme activity in the presence of liposomes
(Fig. 5). Specifically, the double mutant D39A/E47A, which did not
induce an increase in dansyl fluorescence upon the addition of calcium,
did not have enhanced activity in the presence of Ca2. Similarly, the
D39A and E47A singlemutants showed partial stimulation of activity by
calcium and a reduced membrane-bound acceptor fluorescence emis-
sion in the FRET assay. The Ca2 stimulation of the enzyme activity of
theW41Amutantwas also diminished. This observation supports a role
for Trp41 in membrane insertion. However, this mutant showed inter-
mediate stimulation of activity by Ca2, and this observation may indi-
cate that the enzyme could still weakly associate with the membrane.
The results of the activity assay with the W77A mutant are not easily
interpreted, as this form of the enzyme had reduced activity in a mem-
brane-free assay, yet significantly enhanced activity in the presence of
liposomes with and without Ca2. These anomalous results, along with a
lowyield from theprotein expression andpurificationprotocol that proved
to be successful with other forms of the prepared enzyme, suggest that this
substitution may have destabilized the native conformation.
TheCatalytic Domain—8R-LOXhas 30% sequence identity to rabbit
15S-LOX1, for which a crystal structure has been reported (8). The
structural determination of 15S-LOX1 required the presence of an aryl
carboxylate competitive inhibitor (RS75091) (8). This compound was
crucial in the preparation of diffraction quality crystals of the rabbit
enzyme and further allowed for the identification of the substrate-bind-
ing site. However, the competitive inhibitor does not appear to be a true
substrate mimic, as its carboxylate is positioned proximal to the non-
heme iron, blocking approach to the open position in the coordination
sphere of the metal. In contrast, the surface-exposed Arg403 is thought
to tether the substrate by interaction with the arachidonic acid carbox-
ylate group. Thus, a clear interpretation of conformational differences
between the substrate cavities of the two enzymes is complex, as these
differences may reflect not only specificity and product differences, but
also the fact that one of themodels is of an inhibited enzyme. Neverthe-
less, obvious differences can be described.
In Fig. 6a, the structures of the rabbit and coral LOXs are superim-
posed, with themodels oriented such that the postulated site of entry to
FIGURE 4. Fluorescence emission spectra in the presence of dansyl-liposomes. Wild-type (WT) and mutant 8R-LOXs were mixed with dansyl-liposomes in 50 mM Tris-HCl (pH 7.5),
500 mM NaCl, and 4 mM EDTA and scanned in the absence (black traces) and presence (gray traces) of 6 mM CaCl2 (excitation wavelength of 295 nm).
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the active site is from above (r.m.s.d. of 1.54Å for 576 of 662C- atoms).
The placement of the elements of secondary structure is strikingly con-
served at the “lower” half of the catalytic domain, where the long -hel-
ices clearly overlay. Two of these helices contribute four of the iron-
ligating side chains (His385, His390, His571, and Asn575). At the entrance
side of the catalytic domain, there is more deviation in the positions of
the shorter helices. The most notable difference here is a helical seg-
ment in 8R-LOX that covers access to the catalytic iron. The corre-
sponding region is not ordered in the rabbit structure, and inspection of
the 15S-LOX1 crystal packing context indicates that a helical region
here is not compatiblewith the crystal packing. This observation further
complicates our interpretation of structural differences, as one cannot
rule out the possibility that crystal packing has selected for the observed
rabbit LOX conformation.
The substrate-binding pocket of 8R-LOX is illustrated in Fig. 6b. In
this rendering of a slab through the active site, internal voids appear as
clouds outlining two well resolved inner cavities (for the sake of discus-
sion, denoted Cavity A and Cavity B); the catalytic iron is located in the
larger of these cavities (Cavity A). Both cavities are concealed from bulk
solvent. We have modeled in the 20-carbon substrate such that C-10 is
positioned for H abstraction by Fe3 and C-8 is positioned for attack
byO2 in a pouch flanked byGly428, the position that determines product
stereochemistry (16). It is remarkable that, in comparison with
S-LOX(s), the structural consequence of the presence of the Gly (versus
Ala) on helix 13 (the second helix following the long helix contributing
His385 and His390 to the Fe3 coordination sphere) appears to be pri-
marily one of freeing up space. A significant realignment of this helix,
which forms a substantial fraction of the active site, is not observed.
Two conformational changes are required for our proposed mode of
substrate binding. Movement of Tyr179 into a side pocket of Cavity A
permits association of the substrate carboxylate with the surface-ex-
posed Arg183. In the observed conformation, there is no access to the
catalytic iron, and the repositioning of Tyr179 is also necessary to facili-
tate entry into the active site. Deeper in the pocket, a constriction
between Cavities A and B blocks access to the hydrocarbon tail of
arachidonic acid, but a rotamer change in Leu386 and a slight shift of
Leu628 would open up the constriction. These conformational changes
we propose can be adapted with minimal consequences to the protein
structure, as they are largely confined to rotamer changes that fill exist-
ing pockets. In the structure of 15S-LOX1with inhibitor, the region that
corresponds to the helix that blocks solvent access in 8R-LOX is disor-
dered. (The carboxylate of arachidonic acid has access to the surface-
exposed Arg403 of that enzyme.) Our 8R-LOX structure suggests that
disordering of the helix that contains Tyr189 and Arg183 is not necessary
to gain entry to the active site.
FIGURE 5. Enzyme activity and membrane insertion. a and b, the production of 8R-hydroperoxyeicosatetraenoic acid as measured by the increase in absorbance at 235 nm (path
length of 2 mm) for the wild-type (wt-8RLOX) and double mutant (D39A/E47A) 8R-LOXs, respectively, in the absence (●) and presence (E) of CaCl2 upon mixing with 25 M arachidonic
acid in 260 M large unilamellar vesicles (LUV). Wild-type activity (a) was stimulated 4-fold, whereas D39A/E47A activity (b) was not stimulated with the addition of calcium. Note that
the activity of the mutant enzyme in the absence and presence of calcium was the same as that of the wild-type enzyme in the absence of calcium. c, enhancement of enzyme activity
for wild-type (wt-LOX) and mutant 8R-LOXs and the corresponding membrane binding capacity as measured in a FRET assay in which dansyl-phospholipid incorporated into the
membrane vesicles was an acceptor for Trp fluorescence. AA, arachidonic acid; F517, fluorescence at 517 nm
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DISCUSSION
The binding of human 5-LOX to the nuclear membrane is regulated
by Ca2. Based on the sequence identity to the membrane-targeting
domain of gangrene -toxin and site-directed mutagenesis experi-
ments, Ca2-binding amino acids have been identified in its N-terminal
domain. Calcium has also been shown to promote the binding of 15S-
LOX1 to membranes; however, this interaction does not appear to
require specific Ca2-binding amino acids (7). The structure of 8R-LOX
reveals clearly defined calcium-binding sites in its C2-like domain, and
the chelating residues are conserved in both 5-LOX and gangrene
-toxin. Furthermore, we have presented data consistent with a role for
Ca2 in membrane binding and demonstrated that enzyme activity is
enhanced by Ca2 in the presence of liposomes. Ca2 stimulation of
enzyme activity is likely a result of targeting the enzyme to the mem-
brane phase, where higher concentrations of substrate can be found. In
its marine environment, P. homomalla is osmotically equilibrated with
sea water, which contains 5–10 mM CaCl2. However, the free cytosolic
calcium concentration, like that in typical plant and animal cells, might
be as low as nanomolar. It is unclear whether 8R-LOX translocates to
the membrane during transient calcium stimulation or whether the
bound calcium ions serve as part of a static structural element that
promotes 8R-LOX sequestration at the membrane.
Our data suggest that Ca2 binding stimulates enzyme activity by
targeting 8R-LOX to the membrane. The Ca2-binding ridge with
membrane insertion loops that we have described is on the same side of
the cylindrically shaped LOX molecule as the entrance to the binding
site and thus provides a means to effectively tether the enzyme at the
bilayer and to optimize substrate acquisition. However, we cannot
exclude calcium-induced or membrane binding-induced conforma-
tional changes that might also impact enzyme activity. Although the
correlation of the FRET data with the enzyme activity data suggests that
membrane targeting is a significant part of the activation mechanism,
Boutaud and Brash (26) previously reported an increase in 8R-LOX
activity in the presence of calcium in a membrane-free assay. Thus, the
question remains whether the C2-like domain may be a regulatory
domain as well as a membrane-targeting domain. Preparations of cata-
lytic domain-only LOXs have altered catalytic activity. Although the
proteolytically cleaved catalytic domain of soybean LOX L1 has higher
activity and lower stability (27), the truncated version of 15S-LOX1 has
reduced activity (28). Both observations suggest that there is communi-
cation between the domains, and all x-ray structures available have
revealed extensive contact interfaces that would allow for interdomain
communication. Significantly, calciumbinding to theC2-like domain of
gangrene -toxin results in the ordering of a short segment of the phos-
pholipase domain (4, 24), although it is unclear whether Ca2 impacts
catalytic activity per se or simply enzyme localization.
As mentioned above, LOX N-terminal C2-like domains have been
implicated in membrane binding, and C2 domains are often found in
proteins that participate in Ca2-regulated membrane insertion (3, 29,
30). The sequence identity observed between 5-LOX and the C2-like
domain of gangrene -toxin, a membrane-binding phospholipase, led
investigators to model the N-terminal region of 5-LOX on the -toxin
template and demonstrate that putative surface-exposed tryptophan
residues in 5-LOX-barrel loops are required forCa2-regulatedmem-
brane binding (5). Site-detected mutagenesis studies indicate that cal-
cium is bound in part by a set of acidic residues found at the base of the
-barrel loops (6). Moreover, Ca2 is a key regulator in 5-LOX activa-
tion (6) and nuclear membrane localization (23). However, no crystal
structure is available for 5-LOX, and these calcium and membrane
binding features are lacking in 15S-LOX1.
The affinity of Ca2-loaded C2 domains for membranes varies
among superfamily members; for example, the membrane binding dis-
sociation constants for C2 domains from synaptotagmin I, protein
kinase C, and phospholipase A2 range from 3.4 to 24 M (31).
Although the LOX membrane-binding domain is a variation on a C2
theme, it is a distinctly different module not only in its -barrel topol-
ogy, but also in terms of the Ca2 stabilization of membrane-binding
loops.Where the LOXC2-like domain has a line of Ca2 ions flanked by
membrane insertion loops, the ions bound by typical C2 domains clus-
ter in “jaws” formed by loops that emanate from the barrel. AlthoughC2
FIGURE 6. 8R-LOX. a, superposition of 8R-LOX (blue) and 15S-LOX (green). The elements of secondary structure are drawn as cylinders (-helices) and arrows (-strands). Arachidonic
acid and molecular oxygen are modeled in the active site (gray and red). b, detail of the active-site area. Shown is a slab of a surface rendering in which the contours of both the protein
surface and internal cavities are depicted. The orientation is the same as that in a with arachidonic acid and molecular O2 modeled in the active site (gray and red, respectively) so that
C-10 is located in the open position of the iron coordination sphere and O2 is in the Gly
428 pocket positioned for attack at C-8. Leu386 and Leu628, which form a constriction between
two internal cavities, Cavities A and B, are shown, as are Arg183 and Tyr179 at the C-1 end of the substrate. Movement of Tyr179 into an existing void allows for charge-pairing of Arg183
with the arachidonic acid carboxylate. Gly428 and the iron-ligating residues are included. Those amino acids in gold must undergo conformational changes to accommodate the
substrate as positioned, but are drawn here as observed.
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domain calcium sensors are found in phospholipases, kinases, and
membrane trafficking proteins, homologs of the C2-like domain appear
to be largely restricted to LOXs and bacterial phospholipases (e.g. gan-
grene -toxin). Furthermore, not all of the homologs have the Ca2-
binding amino acids common to 5-LOX, coral LOX, and -toxin.
Tatulian and co-workers (32) have proposed a model for the interac-
tion of 5-LOX with the membrane. Their spectroscopic data suggest
that membrane fluidity is necessary to allow insertion of Trp75 of the
C2-like domain (Trp77 in 8R-LOX) as deep as 8–9 Å from the center of
the bilayer and that 9600 Å2 of LOX make contact with the mem-
brane. Our data for 8R-LOX are consistent with such a model, as the
loop that includes Trp77 is fully extended and mobile, and mutation of
this amino acid resulted in a loss of membrane-binding FRET signal.
Pande et al. (32) have reported a Kd of 0.78 M for binding of 5-LOX to
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine vesicles, a value sig-
nificantly different from that for binding of the isolated C2-like domain
to vesicles of similar composition (0.6 nM) (5). With mixed phosphati-
dylcholine/phosphatidylserine vesicles, we obtained a Kd of 11 M, a
value consistent with some aspects of the membrane-binding mecha-
nisms common to 8R-LOX and 5-LOX.
The structure of 8R-LOX is the first for a LOX that produces a fatty
acid hydroperoxide R-stereoisomer. It is well established that the first
step of the reaction with substrate involves the stereospecific hydrogen
abstraction by the activated Fe3 OH, from position 10D in the case of
8R-LOX (12), to produce a pentadiene free radical intermediate. This
C-10 hydrogen abstraction potentially activates the fatty acid for oxy-
genation at either C-8 or C-12; and as oxygenation is known to occur on
the opposite face of the activated substrate, the product is either the 8R-
or 12S-stereoisomer. As noted previously, anAla (or Ser) is conserved in
the binding site of S-LOXs, and this is replaced with Gly in 8R-LOX and
other LOXs with R specificity; site-directed mutagenesis of Gly428
(Gly427 in the numbering scheme of Coffa and Brash (16)) to Ala in
8R-LOX yields 12S-product, whereas the corresponding Ala-to-Gly
mutation in mouse 12S-LOX produces 8R-product (16). One of the
implications of this previous study relates to the head-to-tail orientation
of substrate binding in the active site, and we used the prediction of
tail-first binding for 8R-LOX tomodel arachidonic acid in the substrate-
binding cavity (Fig. 6b). The contours of the pocket support the idea that
one molecule of O2 can be accommodated in a pouch between the
catalytic iron and the protein surface, thus facilitating 8R oxygenation.
Less clear at our current structural resolution of 3.2 Å is what prevents
reaction with molecular oxygen at C-12 of the substrate in the deeper
recesses of the pocket. The 8R-LOX G428A mutant yields the 12S-
product, yet its activity is 20% of that of the wild-type enzyme (16). A
possible interpretation of this result is that the space available to O2 at
position 12 is suboptimal. In future studies, we will crystallize the
8R-LOX G428A mutant and examine this issue directly. In both the
8R-LOX and 15S-LOX1 structures, there appears to be room in the
cavity for both substrate and O2 beyond the catalytic iron, where oxy-
genation at C-12 (or C-15 in 15-LOX) would occur. However, the pres-
ence of a constriction thatmust open to accommodate the tail of arachi-
donic acid as described above for 8R-LOX and the fact that
interpretations of cavity contour differences in the rabbit and coral
enzymes are complicated by differences in crystallization conditions
(the former in the presence of inhibitor and the latter in the absence of
substrate) make it difficult to position the tail or oxygen with certainty
beyond the catalytic iron.
What is clear from the current structure determination and compar-
isonwith 15S-LOX1 is that the presence of the critical glycine (Gly428) of
8R-LOX has minor effects on the structure, other than creation of a
small side pocket that can potentially accommodate O2 (Fig. 6). For
8R-LOX, with substrate-bound hydrocarbon tail first, Gly428 leaves
space for an oxygen pocket close to C-8, and it appears that this,
together with shielding of the other reactive positions by the protein,
leads to the specific production of the 8R-hydroperoxide product.
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